
Asia Pacific Infant, Child, and Maternal Probiotic Supplements Market
No. of Pages: 92 | Report Code: BMIRE00027129 | Category: Consumer Goods
No. of Pages: 92 | Report Code: BMIRE00027129 | Category: Consumer Goods
The Asia Pacific infant, child, and maternal probiotic supplements market is expected to grow from US$ 201.82 million in 2022 to US$ 346.65 million by 2028; it is estimated to grow at a CAGR of 9.4% from 2022 to 2028.
Many prominent manufacturers of probiotics are investing in research and development to develop reliable and science-backed probiotic supplements for infants and pregnant women. Further, they are conducting research to gain a deeper understanding of probiotics' benefits for infants, children, and expecting mothers. New research published in the Journal Microorganisms stated that probiotic supplementation during late pregnancy or lactation and breastfeeding could reduce the risk of mastitis. Similarly, in April 2019, DSM, a major food and nutritional ingredient manufacturer, conducted a study on the effects of probiotic supplementation in reducing infant colic in breastfed babies. BioCare, a fully owned subsidiary of DSM, funded this study and used probiotic strains, namely Lactobacillus rhamnosus and Lactobacillus reuteri, on breastfed babies aged 4 to 12 weeks for 28 days. The study found that breastfed babies supplemented with probiotics were less exposed to colic. The overall cry and fuss time was reduced by 163 minutes.
With the growing demand for infant and maternal probiotics products, manufacturers are innovating their products to increase their customer base and boost revenues. They are launching convenient probiotic delivery formats, such as drops, sticks, sachets, gummies, and powder, for easy consumption by infants and toddlers. These convenient delivery formats of probiotic supplements are gaining high acceptance in Asia Pacific. Thus, such R&D activities and growing studies on probiotic supplements are expected to boost the infant, child, and maternal probiotic supplements market growth over the forecast period.
With new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the Asia Pacific infant, child, and maternal probiotic supplements market growth at a notable CAGR during the forecast period.
Strategic insights for the Asia Pacific Infant, Child, and Maternal Probiotic Supplements provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market. The geographic scope of the Asia Pacific Infant, Child, and Maternal Probiotic Supplements refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.Asia Pacific Infant, Child, and Maternal Probiotic Supplements Strategic Insights
Asia Pacific Infant, Child, and Maternal Probiotic Supplements Report Scope
Report Attribute
Details
Market size in 2022
US$ 201.82 Million
Market Size by 2028
US$ 346.65 Million
Global CAGR (2022 - 2028)
9.4%
Historical Data
2020-2021
Forecast period
2023-2028
Segments Covered
By Form
By End User
Regions and Countries Covered
Asia-Pacific
Market leaders and key company profiles
Asia Pacific Infant, Child, and Maternal Probiotic Supplements Regional Insights
Asia Pacific Infant, Child, and Maternal Probiotic Supplements Market Segmentation
The market for Asia Pacific infant, child, and maternal probiotic supplements market is segmented into form, end user, and country. Based on form, the market is categorized into capsules and soft gels, gummies, liquid, and others. Based on end user, the market is segmented into infant and toddler, children, and maternal women. Based on country, the Asia Pacific infant, child, and maternal probiotic supplements market is segmented into China, Japan, Australia, New Zealand, and the Rest of Asia Pacific.
Asia Pacific Infant, Child, and Maternal Probiotic Supplements Market —Companies Mentioned
Bayer Corporation, Nestlé S.A., BioGaia AB, and Nordic Naturals are a few major companies operating in the Asia Pacific infant, child, and maternal probiotic supplements market.
The Asia Pacific Infant, Child, and Maternal Probiotic Supplements Market is valued at US$ 201.82 Million in 2022, it is projected to reach US$ 346.65 Million by 2028.
As per our report Asia Pacific Infant, Child, and Maternal Probiotic Supplements Market, the market size is valued at US$ 201.82 Million in 2022, projecting it to reach US$ 346.65 Million by 2028. This translates to a CAGR of approximately 9.4% during the forecast period.
The Asia Pacific Infant, Child, and Maternal Probiotic Supplements Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Infant, Child, and Maternal Probiotic Supplements Market report:
The Asia Pacific Infant, Child, and Maternal Probiotic Supplements Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Asia Pacific Infant, Child, and Maternal Probiotic Supplements Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Asia Pacific Infant, Child, and Maternal Probiotic Supplements Market value chain can benefit from the information contained in a comprehensive market report.